GIC Sub-Industry »Biotechnology« (200+)
| Symbol | Industry | Market Cap | VRT | Buy Signal | Risk | RS (IBD) | Div. Yield |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie |
Biotechnology
Immunology, Oncology |
387B | 49 | 0.34 | 78 | 57 | 3.3% |
| AMGN Amgen |
Biotechnology
Biologics, Biosimilars, Oncology |
198B | 67 | 0.40 | 69 | 79 | 3.2% |
| GILD Gilead Sciences |
Biotechnology
Antivirals, Oncology, HIV |
176B | 58 | -0.41 | 90 | 87 | 2.8% |
| VRTX Vertex |
Biotechnology
CF Modulators, Gene Therapy, Pain |
118B | 51 | -0.24 | 88 | 54 | - |
| REGN Regeneron |
Biotechnology
Injection, Ophthalmology |
81.0B | 54 | 0.03 | 89 | 79 | 0.5% |
| ARGX argenx |
Biotechnology
Vygart, Efgartigimod |
52.0B | 53 | -0.16 | 51 | 69 | - |
| HLN Haleon |
Biotechnology
Toothpaste, Vitamins, Cold-Remedy |
46.6B | 56 | 0.28 | 92 | 54 | 1.8% |
| ALNY Alnylam |
Biotechnology
Rna Therapeutics, Amyloidosis |
44.7B | 35 | -2.01 | 25 | 15 | - |
| ONC BeiGene |
Biotechnology
BTK-Inhibitor, Anti-PD-1 |
39.2B | 63 | -0.44 | 35 | 78 | - |
| INSM Insmed |
Biotechnology
Liposomal Antibiotic, DPP1 |
32.0B | 48 | -0.54 | 35 | 87 | - |
| BIIB Biogen |
Biotechnology
Multiple Sclerosis, Spinal |
29.5B | 60 | 0.10 | 93 | 86 | - |
| 22UA BioNTech SE |
Biotechnology
Cancer Vaccines, Immunotherapies |
28.7B | 22 | -0.17 | 86 | 21 | - |
| NTRA Natera |
Biotechnology
Panorama, Horizon, Vistara |
27.5B | 54 | 0.06 | 31 | 69 | - |
| BNTX BioNTech SE |
Biotechnology
Cancer Immunotherapies |
27.2B | 30 | 0.14 | 89 | 37 | - |
| UTHR United Therapeutics |
Biotechnology
Treprostinil, Orenitram, Unituxin |
21.2B | 57 | -0.30 | 93 | 82 | - |
| GMAB Genmab AS |
Biotechnology
Antibody Therapies, Oncological |
20.2B | 73 | -0.67 | 84 | 84 | - |
| INCY Incyte |
Biotechnology
JAKAFI, MONJUVI, PEMAZYRE |
19.6B | 65 | -0.04 | 89 | 85 | - |
| RVMD Revolution |
Biotechnology
RAS Inhibitors, Companion |
18.6B | 48 | -0.21 | 53 | 97 | - |
| MRNA Moderna |
Biotechnology
Vaccines, Respiratory, Oncology |
17.2B | 41 | -0.24 | 35 | 92 | - |
| ROIV Roivant Sciences |
Biotechnology
Antibody, Small-Molecule, Inhaled |
14.7B | 45 | 1.36 | 45 | 97 | - |
| ERF Eurofins |
Biotechnology
Testing, Laboratory, Diagnostics |
14.2B | 60 | -0.54 | 81 | 64 | 1.1% |
| BIM Biomerieux |
Biotechnology
Chromogenic Media, Blood Culture |
13.7B | 42 | -1.24 | 76 | 10 | 0.7% |
| ASND Ascendis Pharma AS |
Biotechnology
TransCon, Hormone, Parathyroid |
13.6B | 40 | -0.79 | 30 | 83 | - |
| NBIX Neurocrine |
Biotechnology
Movement, Endocrine, Psychiatric |
13.6B | 39 | -0.86 | 88 | 43 | - |
| IONS Ionis |
Biotechnology
RNA-Targeted, Neurological, Rare |
13.5B | 49 | -0.12 | 50 | 96 | - |
| RGC Regencell |
Biotechnology
Herbal, Capsule, Syrup, Extract |
13.5B | 36 | 0.13 | 78 | 96 | - |
| BBIO BridgeBio Pharma |
Biotechnology
ATTR-CM, Achondroplasia |
12.2B | 41 | 0.17 | 30 | 93 | - |
| EXEL Exelixis |
Biotechnology
Cancer, Medicines, Tablets |
11.5B | 54 | -0.32 | 86 | 63 | - |
| RNA Avidity Biosciences |
Biotechnology
RNA Therapeutics, Antibody |
11.2B | 45 | 1.02 | 30 | 93 | - |
| MDGL Madrigal |
Biotechnology
Rezdiffra, MASH, Thyroid |
11.1B | 41 | -0.07 | 30 | 80 | - |
| BMRN Biomarin |
Biotechnology
Enzyme Replacement, Growth |
11.1B | 22 | -1.16 | 65 | 26 | - |
| SMMT Summit Therapeutics |
Biotechnology
Ivonescimab, Bispecific Antibody |
10.9B | 15 | -0.95 | 65 | 6 | - |
| QIA QIAGEN |
Biotechnology
Sample, Purification, PCR |
10.6B | 51 | -0.17 | 87 | 54 | 5.2% |
| ARWR Arrowhead |
Biotechnology
Plozasiran, Zodasiran |
9.03B | 59 | -1.23 | 33 | 99 | - |
| HALO Halozyme |
Biotechnology
Enzyme, Injection, Antibody |
8.99B | 63 | -0.32 | 85 | 76 | - |
| PRAX Praxis Precision |
Biotechnology
Ulixacaltamide, Vormatrigine |
8.48B | 51 | 0.95 | 65 | 99 | - |
| ABVX Abivax |
Biotechnology
Immunomodulator Candidate, Bowel |
8.24B | 32 | -0.53 | 35 | 99 | - |
| ABVX Abivax American |
Biotechnology
Drug Candidate, Phase 3, Phase 2b |
8.19B | 30 | 0.15 | 35 | 99 | - |
| KRYS Krystal Biotech |
Biotechnology
Gene Therapy, Rare Skin Diseases |
7.76B | 58 | 0.99 | 76 | 94 | - |
| CYTK Cytokinetics |
Biotechnology
Cardiac Activator, Cardiac |
7.73B | 42 | 0.17 | 30 | 90 | - |
| GRFS Grifols |
Biotechnology
Immunoglobulin, Albumin, Clotting |
7.65B | 48 | 0.63 | 72 | 67 | 1.6% |
| NUVL Nuvalent |
Biotechnology
Ros1 Inhibitor, Alk Inhibitor |
7.48B | 41 | -0.40 | 65 | 77 | - |
| PCVX Vaxcyte |
Biotechnology
Pneumococcal, Streptococcus |
7.01B | 34 | -0.21 | 65 | 85 | - |
| RYTM Rhythm |
Biotechnology
Imcivree, Setmelanotide, Obesity |
6.84B | 42 | -0.30 | 35 | 84 | - |
| BLTE Belite Bio |
Biotechnology
Tinlarebant, LBS-009, Retinal |
6.69B | 51 | 1.06 | 65 | 98 | - |
| KYMR Kymera Therapeutics |
Biotechnology
IRAK4, STAT6, TYK2, Protein |
6.37B | 40 | -0.10 | 35 | 96 | - |
| IBRX Immunitybio |
Biotechnology
Immunotherapy, Cytokine-Fusion |
6.04B | 51 | 0.94 | 28 | 99 | - |
| MIRM Mirum |
Biotechnology
Livmarli, Cholbam, Chenodal |
6.02B | 57 | 0.11 | 40 | 94 | - |
| PTCT PTC Therapeutics |
Biotechnology
Translarna, Emflaza, Upstaza |
6.00B | 66 | -0.55 | 69 | 85 | - |
| COGT Cogent Biosciences |
Biotechnology
Bezuclastinib, CGT4859, Kinase |
5.69B | 48 | 0.16 | 65 | 99 | - |
| ALKS Alkermes |
Biotechnology
Schizophrenia, Bipolar, Alcohol |
5.69B | 49 | -0.17 | 85 | 60 | - |
| GPCR Structure |
Biotechnology
Obesity, Diabetes, Pulmonary |
5.29B | 41 | 0.39 | 58 | 99 | - |
| PTGX Protagonist |
Biotechnology
Peptide, Hepcidin, Integrin |
5.28B | 52 | -0.06 | 35 | 91 | - |
| IMVT Immunovant |
Biotechnology
Monoclonal Antibodies, Autoimmune |
5.24B | 42 | 0.32 | 30 | 90 | - |
| CRNX Crinetics |
Biotechnology
Paltusotine, Atumelnant, CRN09682 |
5.12B | 33 | 0.00 | 28 | 82 | - |
| SRRK Scholar Rock |
Biotechnology
Antibody, Myostatin-Inhibitor |
4.86B | 33 | 0.22 | 65 | 90 | - |
| CELC Celcuity |
Biotechnology
Gedatolisib, CELsignia, PI3K |
4.83B | 55 | 0.10 | 65 | 99 | - |
| CRSP Crispr Therapeutics |
Biotechnology
Gene Editing, CAR-T |
4.76B | 27 | -0.85 | 35 | 43 | - |
| TGTX TG Therapeutics |
Biotechnology
Briumvi, Ublituximab, Tg-1701 |
4.67B | 22 | -0.40 | 30 | 19 | - |
| INDV Indivior Ordinary |
Biotechnology
Buprenorphine, Sublingual |
4.30B | 72 | -0.50 | 62 | 97 | - |
| APGE Apogee |
Biotechnology
Monoclonal Antibodies, Atopic |
4.25B | 43 | -0.45 | 49 | 88 | - |
| ACAD ACADIA |
Biotechnology
Pimavanserin, Trofinetide |
4.25B | 31 | -0.53 | 25 | 54 | - |
| ADMA ADMA Biologics |
Biotechnology
Immunoglobulin, Hepatitis |
4.13B | 31 | -0.94 | 35 | 22 | - |
| CGON CG Oncology |
Biotechnology
Bladder Cancer, Oncolytic |
4.07B | 47 | 0.63 | 30 | 94 | - |
| ACLX Arcellx |
Biotechnology
DdCAR, Anitocabtagene Autoleucel |
3.93B | 23 | -0.50 | 65 | 19 | - |
| GRAL GRAIL |
Biotechnology
Cancer Test, Diagnostic Aid |
3.90B | 38 | -0.47 | 36 | 98 | - |
| LGND Ligand |
Biotechnology
Vaccines, Antivirals, Oncology |
3.78B | 62 | -0.69 | 74 | 80 | - |
| ERAS Erasca |
Biotechnology
Naporafenib, ERAS-007, ERAS-601 |
3.68B | 43 | 0.89 | 35 | 99 | - |
| CNTA Centessa |
Biotechnology
Sleep Disorder Drug, Ox2R Agonist |
3.59B | 38 | -0.77 | 30 | 83 | - |
| NAMS NewAmsterdam |
Biotechnology
Obicetrapib, Ezetimibe, LDL-C |
3.53B | 36 | -0.04 | 30 | 86 | - |
| DNLI Denali Therapeutics |
Biotechnology
RIPK1 Inhibitor, eIF2B Activator |
3.39B | 33 | -0.07 | 65 | 82 | - |
| VKTX Viking Therapeutics |
Biotechnology
VK2809, VK5211, VK0612, VK2735 |
3.38B | 23 | -1.45 | 65 | 12 | - |
| KNSA Kiniksa |
Biotechnology
ARCALYST, Vixarelimab, KPL-387 |
3.23B | 56 | 0.74 | 42 | 90 | - |
| XENE Xenon |
Biotechnology
Epilepsy, Depression, Bipolar |
3.17B | 34 | -0.29 | 84 | 61 | - |
| LEGN Legend Biotech |
Biotechnology
CAR-T Therapy, Multiple Myeloma |
3.17B | 13 | -1.09 | 35 | 2 | - |
| ARQT Arcutis |
Biotechnology
Topical Cream, Topical Foam, JAK1 |
3.13B | 44 | -0.25 | 32 | 94 | - |
| VERA Vera Therapeutics |
Biotechnology
Atacicept, MAU868, VT-109 |
3.09B | 42 | 0.20 | 65 | 94 | - |
| ALMS Alumis |
Biotechnology
TYK2 Inhibitor, CNS TYK2 |
3.06B | 43 | 0.26 | 65 | 99 | - |
| VCYT Veracyte |
Biotechnology
Thyroid, Prostate, Bladder |
3.01B | 28 | -0.32 | 36 | 30 | - |
| IRON Disc Medicine |
Biotechnology
Bitopertin, DISC-0974, DISC-3405 |
3.01B | 42 | -1.01 | 45 | 70 | - |
| CPRX Catalyst |
Biotechnology
Firdapse, Fycompa, Ruzurgi, Agamree |
2.99B | 42 | -0.18 | 82 | 56 | - |
| EWTX Edgewise |
Biotechnology
EDG-5506, EDG-7500, Pipeline |
2.98B | 38 | 0.47 | 65 | 94 | - |
| DYN Dyne Therapeutics |
Biotechnology
Therapeutics, Neuromuscular |
2.95B | 33 | -0.07 | 65 | 70 | - |
| TWST Twist Bioscience |
Biotechnology
Synthetic Genes, Oligo Pools, NGS |
2.89B | 27 | 0.12 | 35 | 89 | - |
| APLS Apellis |
Biotechnology
EMPAVELI, SYFOVRE, Pegcetacoplan |
2.86B | 41 | -0.64 | 35 | 48 | - |
| IDYA Ideaya Biosciences |
Biotechnology
Kinase, Helicase, PARP, ADC |
2.82B | 43 | -0.12 | 28 | 84 | - |
| VRDN Viridian |
Biotechnology
Monoclonal Antibody, IGF-1R |
2.78B | 43 | 0.21 | 20 | 92 | - |
| TVTX Travere |
Biotechnology
Filspari, Thiola, Sparsentan |
2.78B | 42 | -0.16 | 29 | 78 | - |
| IMNM Immunome |
Biotechnology
Gamma Secretase Inhibitor |
2.72B | 41 | -0.03 | 56 | 97 | - |
| BEAM Beam Therapeutics |
Biotechnology
Base Editing Therapies |
2.69B | 28 | -0.15 | 65 | 83 | - |
| RCUS Arcus Biosciences |
Biotechnology
Cancer, Antibody, Inhibitor |
2.60B | 42 | -0.39 | 35 | 94 | - |
| SYRE Spyre Therapeutics |
Biotechnology
Antibody, Integrin, TL1A, IL-23 |
2.48B | 43 | -0.19 | 61 | 95 | - |
| MLYS Mineralys |
Biotechnology
Aldosterone Synthase Inhibitor |
2.44B | 50 | 0.51 | 65 | 95 | - |
| RARE Ultragenyx |
Biotechnology
Enzyme, Gene, Antibody, Metabolic |
2.32B | 19 | -1.70 | 35 | 7 | - |
| DNTH Dianthus |
Biotechnology
Monoclonal Antibody, Complement |
2.31B | 37 | 0.32 | 30 | 97 | - |
| GLPG Galapagos |
Biotechnology
CAR-T, Oncology, Immunology |
2.23B | 44 | 0.09 | 89 | 67 | - |
| GLPG Galapagos |
Biotechnology
Oncology, Immunology, CAR-T |
2.20B | 36 | -0.22 | 81 | 53 | - |
| RXRX Recursion |
Biotechnology
REC-994, REC-2282, REC-4881 |
2.18B | 10 | -0.99 | 30 | 9 | - |
| SRPT Sarepta |
Biotechnology
Exon-Skipping Injectables, Gene |
2.13B | 18 | -0.84 | 29 | 8 | - |
| SLNO Soleno Therapeutics |
Biotechnology
Diazoxide, Prader-Willi, Rare |
2.07B | 21 | -0.83 | 65 | 7 | - |
| OLMA Olema |
Biotechnology
Palazestrant, OP-3136 |
2.03B | 40 | -0.41 | 30 | 99 | - |
| NUVB Nuvation Bio |
Biotechnology
Taletrectinib, Safusidenib |
1.95B | 47 | -0.37 | 30 | 97 | - |
| MESO Mesoblast |
Biotechnology
Cell Therapy, Stem Cell |
1.94B | 15 | -0.44 | 50 | 62 | - |
| AUPH Aurinia |
Biotechnology
Immunosuppressant, B-Cell Inhibitor |
1.92B | 59 | -0.55 | 78 | 85 | - |
| ZBIO Zenas BioPharma |
Biotechnology
Obexelimab, ZB002, ZB004, ZB001 |
1.91B | 42 | 0.11 | 65 | 93 | - |
| ARDX Ardelyx |
Biotechnology
Ibs-Constipation |
1.87B | 42 | 0.11 | 34 | 89 | - |
| ZLAB Zai Lab |
Biotechnology
Oncology, Immunology, Neurology |
1.84B | 10 | -0.73 | 25 | 6 | - |
| VCEL Vericel Ord |
Biotechnology
Cartilage, Skin, Burns, Therapy |
1.82B | 31 | -0.89 | 79 | 11 | - |
| SNDX Syndax |
Biotechnology
Menin Inhibitor, CSF-1R Antibody |
1.77B | 40 | 0.38 | 30 | 91 | - |
| STOK Stoke Therapeutics |
Biotechnology
Dravet Syndrome, Optic Atrophy |
1.76B | 53 | 0.21 | 30 | 98 | - |
| CRVS Corvus |
Biotechnology
ITK Inhibitor, A2A Antagonist |
1.76B | 38 | -0.68 | 35 | 99 | - |
| PHVS Pharvaris BV |
Biotechnology
Deucrictibant, Oral Capsule, Oral |
1.76B | 42 | 0.21 | 65 | 84 | - |
| NRIX Nurix Therapeutics |
Biotechnology
BTK Degrader, CBL-B Inhibitor |
1.73B | 27 | -0.16 | 65 | 87 | - |
| ZYME Zymeworks Common |
Biotechnology
Bispecific Antibodies |
1.73B | 41 | -0.27 | 39 | 92 | - |
| RAPT RAPT Therapeutics |
Biotechnology
Zelnecirnon, Tivumecirnon, CCR4 |
1.67B | 41 | 0.27 | 65 | 99 | - |
| BCRX BioCryst |
Biotechnology
Antiviral, HAE, Complement, Factor |
1.66B | 27 | -1.02 | 38 | 8 | - |
| MBX MBX Biosciences |
Biotechnology
Peptide Prodrug, GLP-1 Antagonist |
1.65B | 43 | -0.28 | 65 | 99 | - |
| IMCR Immunocore Holdings |
Biotechnology
Kimmtrak, Tebentafusp |
1.64B | 40 | -0.19 | 73 | 36 | - |
| OCS Oculis Holding |
Biotechnology
Topical Steroid, Biologic |
1.64B | 37 | 0.14 | 35 | 89 | - |
| CLDX Celldex |
Biotechnology
Monoclonal Antibody, Bispecific |
1.63B | 27 | -0.23 | 35 | 68 | - |
| SION Sionna |
Biotechnology
Galicaftor, Navocaftor, SION-109 |
1.61B | 42 | 0.16 | 46 | 94 | - |
| TNGX Tango Therapeutics |
Biotechnology
PRMT5 Inhibitors, Brain-Penetrant |
1.61B | 53 | 0.68 | 65 | 99 | - |
| AGIO Agios Pharm |
Biotechnology
Pyrimidine Kinase Activator |
1.60B | 16 | -1.18 | 35 | 8 | - |
| ALVO Alvotech |
Biotechnology
Biosimilar, Autoimmune, Oncology |
1.60B | 16 | -0.19 | 39 | 6 | - |
| TYRA Tyra Biosciences |
Biotechnology
FGFR, Precision, Platform |
1.57B | 45 | 1.56 | 28 | 98 | - |
| MNKD MannKind |
Biotechnology
Inhaled Insulin, Insulin Pump |
1.56B | 40 | 0.49 | 35 | 76 | - |
| ORKA Oruka Therapeutics |
Biotechnology
Monoclonal Antibody |
1.52B | 43 | 0.10 | 65 | 98 | - |
| NTLA Intellia |
Biotechnology
Gene Editing, In Vivo, CAR-T, NK |
1.51B | 35 | -0.34 | 35 | 81 | - |
| MEDCL Medincell |
Biotechnology
Antipsychotic, Analgesic |
1.50B | 55 | -0.11 | 34 | 78 | - |
| GLUE Monte Rosa |
Biotechnology
MGD Pipeline, MRT-2359, MRT-6160 |
1.49B | 47 | -0.33 | 29 | 99 | - |
| NVAX Novavax |
Biotechnology
Covid-19 Vaccine, Nanoparticle |
1.44B | 32 | -0.08 | 35 | 71 | - |
| BHVN Biohaven |
Biotechnology
Neurology, Immunology, Oncology |
1.43B | 22 | 0.22 | 57 | 33 | - |
| QURE Uniqure |
Biotechnology
Gene Therapy, Hemophilia B |
1.42B | 42 | -0.55 | 35 | 91 | - |
| PHARM Pharming |
Biotechnology
Recombinant C1-Inhibitor, Oral |
1.41B | 53 | -0.39 | 51 | 79 | - |
| KOD Kodiak Sciences |
Biotechnology
Anti-VEGF Biopolymer, Anti-Il6 |
1.41B | 52 | 0.76 | 65 | 99 | - |
| BTX BlackRock |
Biotechnology
Technology, Private Equity, Mutual |
1.40B | 16 | -0.17 | 67 | 20 | 12.7% |
| ATAI ATAI Life Sciences |
Biotechnology
Depression Treatment |
1.37B | 39 | 0.18 | 30 | 89 | - |
| PGEN Precigen |
Biotechnology
Gene Therapy, Cell Therapy |
1.36B | 47 | 0.54 | 35 | 97 | - |
| CAPR Capricor |
Biotechnology
Deramiocel, Exosome Vaccine |
1.34B | 46 | 0.61 | 35 | 99 | - |
| ANAB AnaptysBio |
Biotechnology
Rosnilimab, ANB032, ANB033 |
1.34B | 42 | 0.89 | 30 | 98 | - |
| RLAY Relay Therapeutics |
Biotechnology
RLY-2608, RLY-4008, RLY-8161 |
1.33B | 53 | 0.01 | 65 | 97 | - |
| IMTX Immatics |
Biotechnology
TCR Bispecifics, ACT Cell |
1.29B | 38 | 0.13 | 35 | 93 | - |
| TSHA Taysha Gene |
Biotechnology
Gene Therapy, Neurological |
1.26B | 43 | -0.06 | 65 | 94 | - |
| UPB Upstream Bio |
Biotechnology
Asthma, Polyps, Copd |
1.26B | 37 | -0.32 | 25 | 97 | - |
| DBVT DBV Technologies |
Biotechnology
Viaskin Peanut, Viaskin Milk |
1.22B | 36 | 0.34 | 30 | 99 | - |
| IVA Inventiva S.A |
Biotechnology
Lanifibranor, Odiparcil, Tgf-Beta |
1.20B | 38 | 0.09 | 30 | 94 | - |
| SANA Sana Biotechnology |
Biotechnology
Islet Cell Therapy, CAR-T Cell |
1.18B | 37 | -0.10 | 65 | 86 | - |
| DAWN Day One |
Biotechnology
Tovorafenib, Day301, Vrk1 Inhibitor |
1.15B | 23 | 0.34 | 33 | 87 | - |
| CMPX Compass |
Biotechnology
Trocimig, CTX-471, CTX-8371 |
1.14B | 51 | 0.69 | 65 | 97 | - |
| MLTX MoonLake |
Biotechnology
Sonelokimab, Nanobody, IL-17A |
1.11B | 16 | -0.67 | 34 | 9 | - |
| CDNA CareDx |
Biotechnology
AlloSure, AlloMap, AlloSeq |
1.09B | 31 | 0.25 | 36 | 76 | - |
| ABCL Abcellera Biologics |
Biotechnology
Antibody, Drug, Candidate |
1.08B | 25 | -0.66 | 66 | 21 | - |
| NNNN Anbio |
Biotechnology
Antigen, Immunoassay |
1.08B | 68 | -0.91 | 78 | 97 | - |
| SVRA Savara |
Biotechnology
Inhaled Immunostimulant, Orphan |
1.08B | 48 | -1.00 | 57 | 93 | - |
| VIR Vir Biotechnology |
Biotechnology
Antibodies, Vaccines, T-Cell |
1.04B | 21 | -0.25 | 30 | 82 | - |
| IOVA Iovance |
Biotechnology
Amtagvi, Proleukin, Lifileucel |
1.01B | 17 | 0.14 | 35 | 49 | - |
| BBOT BridgeBio Oncology |
Biotechnology
KRAS Inhibitor, HER2 Therapy |
1.01B | 28 | -1.20 | 50 | 20 | - |
| OPK Opko Health |
Biotechnology
Diagnostics, Rayaldee, 4Kscore |
1.00B | 14 | -1.22 | 34 | 14 | - |
| URGN UroGen Pharma |
Biotechnology
Jelmyto, UGN-102, UGN-103 |
999M | 40 | -0.38 | 34 | 88 | - |
| ORIC Oric |
Biotechnology
Kinase Inhibitor, AR Pathway, CD73 |
999M | 31 | -0.26 | 65 | 68 | - |
| NANO Nanobiotix S.A |
Biotechnology
Nanoparticle Radiotherapy |
999M | 32 | 1.05 | 30 | 99 | - |
| SPRY ARS |
Biotechnology
Nasal Epinephrine Spray |
988M | 15 | -1.02 | 32 | 12 | - |
| PVLA Palvella |
Biotechnology
Rapamycin Gel, Rare Dermatology |
973M | 42 | -0.99 | 57 | 98 | - |
| GHRS GH Research |
Biotechnology
Mebufotenin, Inhalable |
971M | 39 | -0.04 | 65 | 73 | - |
| CTMX CytomX Therapeutics |
Biotechnology
Antibody-Drug Conjugate, T-Cell |
961M | 48 | -0.09 | 35 | 99 | - |
| CSTL Castle Biosciences |
Biotechnology
Melanoma, Squamous, Esophagus |
956M | 48 | -0.39 | 47 | 82 | - |
| AVBP ArriVent |
Biotechnology
Firmonertinib, ARR-217, ARR-002 |
902M | 23 | -0.94 | 65 | 44 | - |
| GERN Geron |
Biotechnology
Telomerase Inhibitor, Oncology |
875M | 14 | 0.13 | 20 | 66 | - |
| XNCR Xencor |
Biotechnology
Monoclonal Antibodies, Bispecific |
863M | 20 | -0.52 | 33 | 53 | - |
| ANNX Annexon |
Biotechnology
Antibody, Fragment, Oral |
854M | 50 | -0.12 | 45 | 98 | - |
| VLA Valneva SE |
Biotechnology
Vaccines, Chikungunya, Lyme, Zika |
845M | 32 | -0.14 | 35 | 70 | - |
| BCAX Bicara |
Biotechnology
Ficerafusp Alfa, Bifunctional |
841M | 27 | -0.90 | 48 | 68 | - |
| JANX Janux Therapeutics |
Biotechnology
TRACTr, TRACIr, JANX007, JANX008 |
825M | 16 | -0.65 | 30 | 2 | - |
| ESPR Esperion |
Biotechnology
Bempedoic Acid, Ezetimibe |
810M | 41 | -0.95 | 37 | 97 | - |
| IRWD Ironwood |
Biotechnology
Linaclotide, Apraglutide, IW-3300 |
796M | 60 | -0.06 | 38 | 99 | - |
| ABUS Arbutus Biopharma |
Biotechnology
RNAi Therapy, PD-L1 Inhibitor, HBV |
794M | 25 | -0.51 | 35 | 47 | - |
| KALV Kalvista |
Biotechnology
Plasma Kallikrein Inhibitor, Oral |
789M | 42 | -0.18 | 30 | 83 | - |
| MDXG MiMedx |
Biotechnology
Placental Allografts, Amniotic |
757M | 40 | -0.48 | 88 | 6 | - |
| DRUG Bright Minds |
Biotechnology
Serotonin Agonists, Epilepsy |
754M | 45 | -0.73 | 65 | 93 | - |
| CGEM Cullinan Oncology |
Biotechnology
Zipalertinib, CLN-978, CLN-619 |
707M | 41 | -0.38 | 65 | 90 | - |
| ALT Altimmune |
Biotechnology
Obesity, Mash, Liver, Metabolic |
701M | 18 | -0.69 | 28 | 28 | - |
| PRME Prime Medicine |
Biotechnology
Gene Editing, Prime Editor |
688M | 41 | -0.74 | 65 | 89 | - |
| KURA Kura Oncology |
Biotechnology
Ziftomenib, Tipifarnib, KO-2806 |
681M | 14 | -0.69 | 30 | 28 | - |
| ENGN enGene Holdings |
Biotechnology
Bladder Cancer Therapy, Gene |
638M | 39 | 0.02 | 65 | 97 | - |
| SLS Sellas Life |
Biotechnology
Cancer Immunotherapy, CDK9 |
635M | 44 | 0.14 | 65 | 99 | - |
| RIGL Rigel |
Biotechnology
Kinase Inhibitor, Blood Disorder |
633M | 62 | -0.49 | 35 | 79 | - |
| EBS Emergent |
Biotechnology
Vaccines, Antitoxins |
625M | 48 | 0.26 | 89 | 78 | - |
| MGTX MeiraGTx Holdings |
Biotechnology
Gene Therapy, Ocular |
613M | 27 | -0.63 | 34 | 40 | - |
| PROK ProKidney |
Biotechnology
Autologous Selected Renal Cells |
611M | 34 | -0.25 | 65 | 78 | - |
| DRTS Alpha Tau Medical |
Biotechnology
Alpha, DaRT, Radiation, Therapy |
606M | 45 | 1.49 | 65 | 98 | - |
| DSGN Design Therapeutics |
Biotechnology
GeneTAC, Friedreich, Ataxia |
582M | 45 | 0.55 | 35 | 97 | - |
| RGNX Regenxbio |
Biotechnology
Gene Therapy, Retinal Diseases |
565M | 33 | -0.48 | 28 | 67 | - |
| LXEO Lexeo |
Biotechnology
Gene Therapy, Cardiomyopathy |
558M | 42 | -0.42 | 65 | 90 | - |
| IVA Inventiva |
Biotechnology
Lanifibranor, Odiparcil, TGF-β |
557M | 38 | -0.38 | 30 | 95 | - |
| DNA Ginkgo Bioworks |
Biotechnology
Cell Engineering, Biosecurity |
555M | 12 | -0.86 | 34 | 35 | - |
| REPL Replimune |
Biotechnology
Oncolytic Immunotherapy, RP1, RP2 |
551M | 16 | -1.10 | 32 | 21 | - |
| LYEL Lyell Immunopharma |
Biotechnology
CAR T-Cell, IMPT-314, Epi-R |
547M | 44 | 0.15 | 65 | 96 | - |
| KROS Keros Therapeutics |
Biotechnology
KER-050, KER-012, KER-065 |
546M | 46 | -0.44 | 30 | 77 | - |
| VOR Vor Biopharma |
Biotechnology
Trem-Cel, VCAR33, CD33-CLL1 |
540M | 23 | -1.08 | 65 | 81 | - |
| GOSS Gossamer Bio |
Biotechnology
Seralutinib, GB002 |
528M | 45 | -0.27 | 28 | 87 | - |